WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2013> > 5

Volume: Issue: 5

1. The role of monocytes Siglec-1 in stimulating CD4 + and CD8 + T cells proliferation and activation in atherosclerosis Page:414—419
2. Ciprofloxacin non-susceptible Streptococcus pyogenes due to mutations in parC gene and its homology analysis Page:425—429
3. The performance evaluation of dry-type blood cell analyzer Page:467—469
4. Recognition of Russell bodies and Mott cells Page:472—474
5. The laboratory and clinical diagnosis strategy in MYH9 disorders Page:475—478
6. Moving forward with times, improving the cytological diagnosis levels Page:385—388
7. The future trend in laboratory diagnosis of peripheral blood cell morphology Page:389—392
8. Reference intervals for common tests of liver function, electrolytes and blood cell analysis of Chinese adults Page:393—394
9. Analysis of clinical significance on the special thromboelastograph graphics Page:400—404
10. Light transmittance aggregometry with non-adjusted PRP is more suitable for clinical laboratory =monitoring antiplatelet therapy Page:405—409
11. Preparation and evaluation of quality control serum for antinuclear antibody testing Page:410—413
12. To establish a new and simple method of genotyping of hepatitis B virus by PCR-RFLP to analysis on S region Page:420—424
13. An improvement of the turnaround time in clinical laboratories by using the Six Sigma concept Page:457—460
14. Detection of human cytomegalovirus UL97 gene mutations conferring ganciclovir resistance Page:461—466
15. Fluorescence in situ hybridization and aminocytes karyotyping for 1809 aminotic cells assay Page:342—346
16. Molecular diagnostic techniques spearhead the development of clinical laboratory diagnosis Page:321—323
17. The performance evaluation of soluble ST2 detection kit and the clinical application of sST2 in diagnosing heart failure Page:394—398
18. Diagnostic value of Golgi-73 and AFP in primary hepatocelluar carcinoma with single assay or combined detection:a meta-analysis Page:357—361
19. The analysis of the 4 enzymatic assays in enzyme RELA results Page:347—351
20. Molecular inversion probe-based single base mutations of hepatitis B virus resistance gene analysis Page:337—341
21. The potential value of microRNA in the development of tuberculosis and its early diagnosis Page:330—333
22. Pondering on the development of molecular diagnostics in China Page:327—329
23. Appropriate technologies for molecular diagnostic in personalized medicine Page:324—326
24. Investigation of the minimum required months for imprecision analysis Page:386—390
25. Detection of capsular serotype and virulence gene of Klebsiella pneumonia with hypermucoviscosity phenotype Page:379—382
26. Evaluation of value of indirect method in establishing reference intervals of CA72-4 Page:376—378
27. The role of 3 external quality assessment programs in assessment of analytical quality on determination of serum creatinine and urea Page:371—375
28. The expression and clinical significance of circulating tumor cells in small-cell lung cancer Page:362—364
29. The detection of serum protein C for the bronchial asthma patients condition and prognosis assess Page:352—356
30. Application of molecular biology techniques in the diagnosis and treatment of major infectious diseases Page:334—336
31. Quality control rules used in external quality assessment of quantitative assay in clinical laboratories Page:357—358
32. Investigation and improvement of urine albumin measurement in clinical laboratories in Tianjin Page:353—356
33. Investigation and analysis of reference intervals of tumor markers testing in China Page:349—352
34. Evaluation of hepatic fibrosis using Aspartate aminotransferase-to-Platelet Ratio Index in children with biliary atresia Page:337—340
35. The application of capillary electrophoresis in HbA1c and HbA2 detection in beta thalassemia patients Page:329—332
36. The relationship between plasma metabolic profiling and platelets activation on acute myocardium infarction patients Page:325—328
37. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of creatinine-corrected sarcosine in urine Page:321—324
38. Results analysis of serum alanine transaminase measurement in 23 clinical laboratories with target value assigned by reference method Page:318—320
39. Method for the improving of point-of-care HBA1c results harmonization Page:310—312
40. Commutability of certified reference material ERM-DA 471/IFCC for cystatin C measurement Page:306—309
41. Quality assessment and improvement in clinical biochemistry Page:289—291
42. The commutability of reference materials for serum glucose measurements Page:296—300
43. Method comparison and accuracy of 15 commercial serum total protein assays Page:292—295
44. External quality assessment schemes and standardization/harmonization of clinical laboratory measurement Page:359—360
45. The association between ulcerative colitis and TRAIL receptor genetic polymorphisms Page:341—345
46. Thrombelastography prevents deep venous thrombosis in the perioperative period of arthroplasty replacement Page:333—336
47. Quality assessment of seven kinds of sero-enzyme tests in China Page:313—317
48. Quality assurance of clinical biochemistry testing:a mualti-center study based reference interval for clinical chemistry tests in the Chinese population Page:301—305
49. Assessment of the consistency of five standardized cystatin C measurement systems Page:365—370

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.